Tavegil

Medicinal product

(Invented) name

Tavegil

Active substance (s)

Klemastinas

Strength

1 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną, leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R06AA04, Clemastine

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2025-09-12

Date of renewal

Documents

2863_Tavegil_inj_PZ_2025-09-12.docx

2863_Tavegil_inj_PL_2025-09-12.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

1 ml tirpalo yra	1 ml
Klemastinas	1 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118646	104749	1104749	ampulė	2 ml N5		Receptinis	LT/L/25/2863/001	Netiekiama	-	2026-02-01	No	-	-	Download
118647	104750	1104750	ampulė	2 ml N10		Receptinis	LT/L/25/2863/002	Netiekiama	-	2026-02-01	No	-	-

Stadijos

Data	Stadija
2025-09-12	Registruotas